BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 91890)

  • 1. Distinction between endocervical and endometrial adenocarcinoma with immunoperoxidase staining of carcinoembryonic antigen in routine histological tissue specimens.
    Wahlström T; Lindgren J; Korhonen M; Seppälä M
    Lancet; 1979 Dec; 2(8153):1159-60. PubMed ID: 91890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical studies on carcinoembryonic antigen in adenocarcinomas of the uterus.
    Ueda S; Tsubura A; Izumi H; Sasaki M; Morii S
    Acta Pathol Jpn; 1983 Jan; 33(1):59-69. PubMed ID: 6340419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocervical and endometrial adenocarcinoma: an immunoperoxidase and histochemical study.
    Cohen C; Shulman G; Budgeon LR
    Am J Surg Pathol; 1982 Mar; 6(2):151-7. PubMed ID: 7048944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A panel of immunohistochemical stains, including carcinoembryonic antigen, vimentin, and estrogen receptor, aids the distinction between primary endometrial and endocervical adenocarcinomas.
    McCluggage WG; Sumathi VP; McBride HA; Patterson A
    Int J Gynecol Pathol; 2002 Jan; 21(1):11-5. PubMed ID: 11781517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical localization of carcinoembryonic antigen in adenocarcinoma of the endocervix and the endometrium.
    Toki T; Oikawa N; Tase T; Wada Y; Yajima A; Suzuki M
    Tohoku J Exp Med; 1985 May; 146(1):27-32. PubMed ID: 3895576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The distribution of mucins, carcinoembryonic antigen, and mucus-associated antigens in endocervical and endometrial adenocarcinomas.
    Maes G; Fleuren GJ; Bara J; Nap M
    Int J Gynecol Pathol; 1988; 7(2):112-22. PubMed ID: 3294194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical comparison of new monoclonal antibody 1C5 and carcinoembryonic antigen in the differential diagnosis of adenocarcinoma of the uterine cervix.
    Kudo R; Sasano H; Koizumi M; Orenstein JM; Silverberg SG
    Int J Gynecol Pathol; 1990; 9(4):325-36. PubMed ID: 1700970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunohistochemical study of carcinoembryonic antigen of the tissue and cell levels in adenocarcinoma of the uterus].
    Suzuki M; Ohwada M; Tamada T; Shiina Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jun; 37(6):897-902. PubMed ID: 3894535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermediate filaments in endometrial and endocervical carcinomas. The diagnostic utility of vimentin patterns.
    Dabbs DJ; Geisinger KR; Norris HT
    Am J Surg Pathol; 1986 Aug; 10(8):568-76. PubMed ID: 2426982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immunohistochemical discrimination of endometrioid adenocarcinomas.
    Dabbs DJ; Sturtz K; Zaino RJ
    Hum Pathol; 1996 Feb; 27(2):172-7. PubMed ID: 8617459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localization of carcinoembryonic antigen in uterine cervical neoplasia.
    Agarwal S; Sharma S
    Indian J Med Res; 1990 Dec; 92():452-5. PubMed ID: 2079363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Value of ER, VIM, CEA and p16 detection in the diagnosis and differential diagnosis of primary endocervical and endometrial adenocarcinomas].
    Hu WW; Tao JH; Li GM; Xu X; Yang XM
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Mar; 30(3):526-8, 531. PubMed ID: 20335127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinguishing between primary endocervical and endometrial adenocarcinomas: is a 2-marker (Vim/CEA) panel enough?
    Liao CL; Hsu JD; Lee MY; Kok LF; Li YJ; Wang PH; Yao CC; Han CP
    Virchows Arch; 2010 Apr; 456(4):377-86. PubMed ID: 20221633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenocarcinoma of the endocervix--a histochemical study.
    Cooper P; Russell G; Wilson B
    Histopathology; 1987 Dec; 11(12):1321-30. PubMed ID: 3326816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinoembryonic antigen staining of endometrial and endocervical carcinomas.
    van Nagell JR; Goldenberg JR
    Lancet; 1980 Jan; 1(8161):213. PubMed ID: 6153442
    [No Abstract]   [Full Text] [Related]  

  • 16. p16 immunoreactivity may assist in the distinction between endometrial and endocervical adenocarcinoma.
    McCluggage WG; Jenkins D
    Int J Gynecol Pathol; 2003 Jul; 22(3):231-5. PubMed ID: 12819388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunohistochemical demonstration of carcinoembryonic antigen and ultrastructural features of endometrial adenocarcinoma].
    Okudaira Y; Ohtsuru Y; Matsui Y; Sawada M; Ozaki M; Hongo J; Hirota Y; Yamazaki M; Inagaki M
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Feb; 36(2):173-81. PubMed ID: 6366091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.
    Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM
    Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of immunohistochemistry in the differential diagnosis of endometrial carcinomas.
    Dallenbach-Hellweg G; Lang-Avérous G; Hahn U
    APMIS Suppl; 1991; 23():91-9. PubMed ID: 1715731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoprofile of cervical and endometrial adenocarcinomas using a tissue microarray.
    Alkushi A; Irving J; Hsu F; Dupuis B; Liu CL; Rijn M; Gilks CB
    Virchows Arch; 2003 Mar; 442(3):271-7. PubMed ID: 12647218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.